RSS

Chiesi

Dr David Lewis, director of aerosol research at pharmaceutical company Chiesi, discusses how the company is focusing on new technologies to advance drug discvoery and future-proof innovation. Read more

Opinion

Dr David Lewis, director of Aerosol Research Chiesi discusses the environmental concerns that come with pressurised metered dose inhalers (pMDIs). Read more

Opinion

Full-service contract manufacturer of biopharmaceutical proteins, Wacker Biotech, has obtained US Food and Drug Administration (FDA) approval to manufacture reteplase — the active ingredient in the drug Retavase. Read more

News